ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 667,84
1,16%
DAX
18 001,60
0,54%
Brent Oil
83,235
-0,47%
Bitcoin
61 880,42
4,67%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cascadian Therapeutics, Inc. (delisted) (CASC)

  7. Cascadian Therapeutics, Inc. (delisted) (CASC) Actualités

CASC

Cascadian Therapeutics, Inc. (CASC)

Cascadian Therapeutics, Inc. (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CASC
DateHeureSourceTitreSymboleSociété
11/04/201920h00Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/04/201822h54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
22/03/201819h12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
22/03/201811h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
19/03/201820h17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
13/03/201823h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201823h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201815h53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201815h50Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201815h45Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201815h18Edgar (US Regulatory)(25-NSE)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201812h18Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201812h13Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/03/201822h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
16/02/201814h00Business WireSeattle Genetics Announces Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201823h39Business WireSeattle Genetics Commences Tender Offer for Cascadian Therapeutics, Inc.NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201823h29Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201823h28Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
07/02/201823h26Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
01/02/201815h31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201814h26PR Newswire (US)Cascadian (CASC) Alert: Johnson Fistel Investigates Proposed Sale of Cascadian Therapeutics, Inc.; Is $10.00 a Fair Price for...NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201813h23Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201812h30Business WireSeattle Genetics to Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program to Its Oncology PipelineNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
04/01/201814h30GlobeNewswire Inc.Cascadian Therapeutics Announces 2018 Outlook and Recent ProgressNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
02/01/201814h30GlobeNewswire Inc.Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines AgencyNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
29/12/201722h10Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
13/12/201714h35GlobeNewswire Inc.Cascadian Therapeutics Added to the Nasdaq Biotechnology IndexNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
07/12/201722h05GlobeNewswire Inc.Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Can...NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/11/201723h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/11/201722h01GlobeNewswire Inc.Cascadian Therapeutics Reports Third Quarter 2017 Financial ResultsNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:CASC

Dernières Valeurs Consultées

EU
PX4
SBF 120
NASDAQ
MSFT
Microsoft
EU
RI
Pernod Ricard
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
EU
BEL20
Bel 20
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
HO
Thales
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés